{"id":44822,"date":"2012-05-16T03:14:11","date_gmt":"2012-05-16T03:14:11","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/blue-chip-marketing-worldwide-launches-new-mobile-health-care-technology-survey.php"},"modified":"2012-05-16T03:14:11","modified_gmt":"2012-05-16T03:14:11","slug":"blue-chip-marketing-worldwide-launches-new-mobile-health-care-technology-survey","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/blue-chip-marketing-worldwide-launches-new-mobile-health-care-technology-survey.php","title":{"rendered":"Blue Chip Marketing Worldwide Launches New Mobile Health Care Technology Survey"},"content":{"rendered":"<p><p>    NORTHBROOK, IL--(Marketwire -05\/15\/12)-     Blue Chip Patient Recruitment, a division of     Blue Chip Marketing Worldwide, today announced the launch    of its mHealth (mobile health care technology) Survey. The    study will examine the benefits of mobile technology in    clinical    trial recruitment through three separate surveys    targeting patients, physicians and site coordinators. Complete    survey results will be presented at this year's Drug    Information Association (DIA) Conference, June 26, 2012, during    the forum \"The Next Patient Recruitment Frontier: Leveraging    Mobile Health Care Technology (mHealth) to Recruit Patients for    Clinical Trials.\" Neil Weisman, Executive Vice President    and General Manager of Blue Chip Patient Recruitment, will    moderate.  <\/p>\n<p>    \"According to the Center for Information & Study on    Clinical Research Participation, delays in patient recruitment    for clinical trials account for an average of 4.6 months lost    per trial. It is our opinion that this delay can be avoided by    better understanding where and when potential study    participants are most receptive to receiving a message asking    them to enroll in a specific study,\" said Stanton Kawer,    Chairman and CEO of Blue Chip Marketing Worldwide. \"Blue    Chip Patient Recruitment recognizes the significant changes    that the growth in mobile technology has delivered to all    facets of society. We are specifically interested in    identifying how such dynamic platforms can translate to    accelerated enrollment for the clinical trial industry. That is    our charge.\"  <\/p>\n<p>    Blue Chip Patient Recruitment is fielding the mHealth Survey in    three parts over the course of three months (March - May 2012),    directly targeting three core constituencies -- patients,    physicians and trial site coordinators. Selected patient    participants have to currently own a smartphone and\/or tablet.    All participating physicians and site coordinators have to    currently be involved in clinical trials.  <\/p>\n<p>    \"The mHealth Survey will help us to determine ways in which    mobile devices can be used by each of our key audiences to make    them more willing to participate in, engage with, or refer    patients to clinical trials,\" said Neil Weisman. \"In our    technologically savvy world where people are constantly    connected in one way or another, the Survey will be vital in    helping Blue Chip Patient Recruitment create tools that will    connect patients, physicians and research sites to meaningful    clinical trial opportunities.\"  <\/p>\n<p>    About Blue Chip Patient RecruitmentBlue    Chip Patient Recruitment, a division of Blue Chip Marketing    Worldwide, is a global, full-service patient recruitment and    retention agency dedicated to accelerating clinical trial    enrollment. They have proudly delivered success to the world's    top health care corporations for nearly 20 years, across more    than 600 clinical studies. They are recognized for their    scientific approach to clinical trial marketing, their insights    and strategies, their innovative recruitment tactics and their    best in class creative. Most importantly, they are known for    the intelligence and passionate service that they bring to    every study. For more information, visit     <a href=\"http:\/\/www.bcpatientrecruitment.com\" rel=\"nofollow\">http:\/\/www.bcpatientrecruitment.com<\/a>.  <\/p>\n<p>    About Blue Chip Marketing WorldwideFounded in 1982    in Northbrook, Illinois, Blue Chip Marketing Worldwide    (www.bluechipmarketingworldwide.com)    is an independent, full-service global marketing agency that    unites brands to sales to deliver unparalleled results. Through    360 insights, proprietary models and detailed execution, BCMW    delivers core marketing capabilities for the retail, healthcare    and branding sectors. Clients include Procter & Gamble,    Gorton's, Wells Enterprises, Inc. (Blue Bunny Ice Cream),    Fisher Nuts, On-Cor Frozen Foods, LLC, BioSante    Pharmaceuticals, Inc., inVentiv Health and Alva-Amco, among    others.  <\/p>\n<\/p>\n<p>Read more here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/blue-chip-marketing-worldwide-launches-185700643.html;_ylt=A2KJjb1mG7NP1mMArhL_wgt.\" title=\"Blue Chip Marketing Worldwide Launches New Mobile Health Care Technology Survey\">Blue Chip Marketing Worldwide Launches New Mobile Health Care Technology Survey<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NORTHBROOK, IL--(Marketwire -05\/15\/12)- Blue Chip Patient Recruitment, a division of Blue Chip Marketing Worldwide, today announced the launch of its mHealth (mobile health care technology) Survey. The study will examine the benefits of mobile technology in clinical trial recruitment through three separate surveys targeting patients, physicians and site coordinators <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/blue-chip-marketing-worldwide-launches-new-mobile-health-care-technology-survey.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-44822","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/44822"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=44822"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/44822\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=44822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=44822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=44822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}